Predicting kidney disease risk after pre-eclampsia
Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care
NA · Centre Hospitalier le Mans · NCT05056701
This study is trying to see if women who had pre-eclampsia during pregnancy are at higher risk of developing kidney disease later on.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Centre Hospitalier le Mans (other) |
| Locations | 2 sites (Angers and 1 other locations) |
| Trial ID | NCT05056701 on ClinicalTrials.gov |
What this trial studies
This study aims to identify the risk of developing chronic kidney disease (CKD) in women who have experienced pre-eclampsia, a pregnancy-related condition characterized by high blood pressure and protein in the urine. Participants will undergo annual follow-ups for a duration of 10 years to monitor kidney health and other related complications. The study seeks to enhance understanding of the long-term effects of pre-eclampsia on kidney function and overall health. By focusing on this relationship, the study hopes to improve early diagnosis and care for affected patients.
Who should consider this trial
Good fit: Ideal candidates are women who have met the criteria for pre-eclampsia or its complications within the last five years.
Not a fit: Patients with mental disabilities or language barriers that prevent them from understanding the study will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved early detection and management of chronic kidney disease in women who have had pre-eclampsia.
How similar studies have performed: While the relationship between pre-eclampsia and chronic kidney disease is complex, similar studies have indicated a potential link, making this approach both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meeting the preeclampsia criteria or one of its complications (eclampsia, HELLP syndrome) according to the ISSHP 2018 definitions within the last 5 years * Having signed the informed consent * Person affiliated to social security Exclusion Criteria: * Patient with mental disability or language barrier preventing understanding of the study or consent * Person deprived of liberty by judicial or administrative decision * Person under forced psychiatric care * Person subject to a legal protection measure
Where this trial is running
Angers and 1 other locations
- Chu Angers — Angers, France (NOT_YET_RECRUITING)
- Centre Hospitalier Du Mans — Le Mans, France (RECRUITING)
Study contacts
- Study coordinator: Christelle JADEAU
- Email: cjadeau@ch-lemans.fr
- Phone: +33 2 44 71 07 81
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Preeclampsia, chronic kidney disease, preeclampsia